Literature DB >> 15986460

Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats--effect of medium and long chain triglycerides.

Mette Grove1, Gitte P Pedersen, Jeanet L Nielsen, Anette Müllertz.   

Abstract

Simulated intestinal media (SIM) containing bile salt (BS) and phospholipids (PL) with and without medium chain lipolytic products (MC-LP) or long chain lipolytic products (LC-LP) were developed to study the solubility of seocalcitol. Both MC-LP and LC-LP were studied in order to investigate the influence of fatty acid chain length on the in vitro solubility of seocalcitol. The same solubility of seocalcitol was found in media containing either MC-LP or LC-LP. The bioavailability after oral administration of seocalcitol dissolved in medium chain triglyceride (MCT), long chain triglyceride (LCT), and a reference formulation containing propylene glycol (PG) was studied in vivo in rats. The lipid formulations showed a twofold increase in bioavailability compared with the reference formulation, indicating positive effects of lipids on the bioavailability reflecting a better solubility in the intestine and protection against precipitation of seocalcitol in the gastro intestinal tract. There was no difference in the in vivo bioavailability of seocalcitol between the MCT and the LCT solutions, which correlates with the identical in vitro solubility of seocalcitol in SIM containing MC-LP or LC-LP. (c) 2005 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986460     DOI: 10.1002/jps.20403

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Formulation development and optimization using nanoemulsion technique: a technical note.

Authors:  Sheikh Shafiq-un-Nabi; Faiyaz Shakeel; Sushma Talegaonkar; Javed Ali; Sanjula Baboota; Alka Ahuja; Roop K Khar; Mushir Ali
Journal:  AAPS PharmSciTech       Date:  2007-04-06       Impact factor: 3.246

2.  Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs.

Authors:  Sarah Clarysse; Dimitrios Psachoulias; Joachim Brouwers; Jan Tack; Pieter Annaert; Guus Duchateau; Christos Reppas; Patrick Augustijns
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

3.  Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update.

Authors:  Ekarat Jantratid; Niels Janssen; Christos Reppas; Jennifer B Dressman
Journal:  Pharm Res       Date:  2008-04-11       Impact factor: 4.200

4.  Bioavailability of cinnarizine in dogs: effect of SNEDDS loading level and correlation with cinnarizine solubilization during in vitro lipolysis.

Authors:  Anne T Larsen; Pernilla Åkesson; Anna Juréus; Lasse Saaby; Ragheb Abu-Rmaileh; Bertil Abrahamsson; Jesper Østergaard; Anette Müllertz
Journal:  Pharm Res       Date:  2013-08-15       Impact factor: 4.200

5.  Biopharmaceutical modeling of drug supersaturation during lipid-based formulation digestion considering an absorption sink.

Authors:  Cordula Stillhart; Georgios Imanidis; Brendan T Griffin; Martin Kuentz
Journal:  Pharm Res       Date:  2014-06-25       Impact factor: 4.200

6.  Bioavailability of seocalcitol IV: evaluation of lymphatic transport in conscious rats.

Authors:  Mette Grove; Jeanet L Nielsen; Gitte P Pedersen; Anette Müllertz
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

7.  Inclusion of Medium-Chain Triglyceride in Lipid-Based Formulation of Cannabidiol Facilitates Micellar Solubilization In Vitro, but In Vivo Performance Remains Superior with Pure Sesame Oil Vehicle.

Authors:  Wanshan Feng; Chaolong Qin; Elena Cipolla; Jong Bong Lee; Atheer Zgair; Yenju Chu; Catherine A Ortori; Michael J Stocks; Cris S Constantinescu; David A Barrett; Peter M Fischer; Pavel Gershkovich
Journal:  Pharmaceutics       Date:  2021-08-27       Impact factor: 6.525

8.  Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion.

Authors:  Malinda Salim; Gisela Ramirez; Kang-Yu Peng; Andrew J Clulow; Adrian Hawley; Hanu Ramachandruni; Stephane Beilles; Ben J Boyd
Journal:  Mol Pharm       Date:  2020-06-23       Impact factor: 4.939

9.  SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization.

Authors:  Anne T Larsen; Anayo Ogbonna; Ragheb Abu-Rmaileh; Bertil Abrahamsson; Jesper Ostergaard; Anette Müllertz
Journal:  Pharmaceutics       Date:  2012-12-14       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.